AW
CVS icon

Alaethes Wealth’s CVS Health CVS Stock Holding History

Alaethes Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,999
Closed -$968K – 111
2023
Q2 		$968K Buy
13,999
+935
+7% +$66.5K 0.53% 77
2023
Q1 		$971K Buy
13,064
+1,140
+10% +$95.6K 0.57% 76
2022
Q4 		$1.11M Buy
11,924
+592
+5% +$57.1K 0.76% 57
2022
Q3 		$1.08M Buy
11,332
+606
+6% +$60K 0.79% 46
2022
Q2 		$994K Buy
10,726
+2,542
+31% +$248K 0.74% 58
2022
Q1 		$828K Buy
8,184
+8,089
+8,515% +$850K 0.53% 75
2021
Q4 		$10K Hold
95
– – 0.01% 201
2021
Q3 		$8K Hold
95
– – 0.01% 199
2021
Q2 		$8K Buy
+95
New +$7.78K 0.01% 201

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alaethes Wealth's CVS Position: Q3 2023 in Review

Alaethes Wealth sold out of CVS Health (CVS) in Q3 2023, closing a stake of 13,999 shares — an estimated $968K sold.

Alaethes Wealth first reported a position in CVS in Q2 2021 and held it in 9 quarters. The position peaked at $1.11M in Q4 2022. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Alaethes Wealth reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Alaethes Wealth sold 13,999 CVS Health shares in Q3 2023, an estimated $968K.
  • Alaethes Wealth first reported a position in CVS Health in Q2 2021 and held it in 9 quarters.
  • Alaethes Wealth's CVS Health position peaked at $1.11M in Q4 2022.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Alaethes Wealth's 13F filing for Q3 2023, filed 13 Nov 2023.